971 filings
Page 6 of 49
8-K
SRNEQ
Sorrento Therapeutics, Inc.
3 Jun 22
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured Notes
9:00am
425
SRNEQ
Sorrento Therapeutics, Inc.
23 May 22
Business combination disclosure
9:06am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
23 May 22
Other Events
9:05am
4
Czerepak Elizabeth
20 May 22
Sorrento Therapeutics / ELIZABETH CZEREPAK ownership change
5:14pm
4
Tammy Reilly
20 May 22
Sorrento Therapeutics / Tammy Reilly ownership change
5:11pm
3
Tammy Reilly
20 May 22
Sorrento Therapeutics / Tammy Reilly ownership change
5:09pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
18 May 22
Sorrento Therapeutics, Inc. Appoints Former Roche Executive Tammy Reilly to the Board of Directors
4:02pm
10-Q
2022 Q1
SRNEQ
Sorrento Therapeutics, Inc.
Quarterly report
5 May 22
12:00am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
28 Apr 22
Departure of Directors or Certain Officers
9:00am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
4 Apr 22
Results of Operations and Financial Condition
9:01am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
18 Mar 22
Regulation FD Disclosure
4:35pm
425
SRNEQ
Sorrento Therapeutics, Inc.
18 Mar 22
Business combination disclosure
9:03am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
18 Mar 22
Entry into a Material Definitive Agreement
9:01am
10-K
2021 FY
SRNEQ
Sorrento Therapeutics, Inc.
Annual report
11 Mar 22
5:17pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
3 Mar 22
Other Events
5:16pm
424B7
SRNEQ
Sorrento Therapeutics, Inc.
3 Mar 22
Prospectus with selling stockholder info
5:08pm
NT 10-K
SRNEQ
Sorrento Therapeutics, Inc.
1 Mar 22
Notice of late annual filing
4:31pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
17 Feb 22
Other Events
2:05pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
16 Feb 22
Entry into a Material Definitive Agreement
5:29pm
SC 13G
SRNEQ
Sorrento Therapeutics, Inc.
10 Feb 22
Sorrento Therapeutics / VANGUARD ownership change
12:00am